VMP 42185111000001104

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Azelastine 140micrograms/dose nasal spray
BNF code 1202010A0AAABAB
Virtual Therapeutic Moiety Azelastine
Date identifier became valid 25 Aug 2023
Previous product identifier 331057004
Basis of preferred name rINN - Recommended International Non-proprietary
Date of name applicability 25 Feb 2010
Previous name Azelastine 140micrograms/actuation nasal spray
Basis of previous name rINN - Recommended International Non-proprietary
Reason for name change Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units actuation
Unit dose unit of measure actuation
Virtual Product Ingredient
Ingredient Azelastine hydrochloride
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 140.000
Strength value numerator unit microgram
Strength value denominator 1.000
Strength value denominator unit actuation
Ontology Drug Form & Route
Form & Route solutionspray.nasal
Dose Form
Formulation Spray
Drug Route
Route Nasal
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Rhinolast 140micrograms/dose nasal spray (Sigma Pharmaceuticals Plc)
Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd)
Virtual Medicinal Product Packs
Azelastine 140micrograms/dose nasal spray 10 ml
Azelastine 140micrograms/dose nasal spray 20 ml
Azelastine 140micrograms/dose nasal spray 22 ml
Azelastine 140micrograms/dose nasal spray 5 ml

dm+d data retrieved from TRUD: release NHSBSA_4.4.0_20240429000001, imported on 29th April 2024 at 05:07:25.

Feedback